Vivo Capital, LLC - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 57 filers reported holding HOMOLOGY MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q3 2023$432,980
+32.2%
370,0680.0%0.05%
+104.3%
Q2 2023$327,510
-14.1%
370,0680.0%0.02%
-11.5%
Q1 2023$381,170
+81696.1%
370,0680.0%0.03%
-51.9%
Q4 2022$466
-99.9%
370,0680.0%0.05%
-18.2%
Q3 2022$596,000
-18.2%
370,0680.0%0.07%
-9.6%
Q2 2022$729,000
-71.9%
370,068
-56.6%
0.07%
-59.2%
Q1 2022$2,594,000
-16.5%
853,1430.0%0.18%
-4.3%
Q4 2021$3,105,000
-53.8%
853,1430.0%0.19%
-37.9%
Q3 2021$6,714,000
+8.3%
853,1430.0%0.30%
+12.3%
Q2 2021$6,202,000
-22.7%
853,1430.0%0.27%
-5.0%
Q1 2021$8,028,000
-16.7%
853,1430.0%0.28%
-34.4%
Q4 2020$9,632,000
+5.5%
853,1430.0%0.43%
-18.6%
Q3 2020$9,129,000
-31.4%
853,143
-2.6%
0.53%
-44.7%
Q2 2020$13,302,000
-15.1%
875,696
-13.2%
0.95%
-32.8%
Q1 2020$15,673,000
-30.9%
1,008,562
-13.0%
1.42%
-33.2%
Q2 2019$22,696,000
-29.4%
1,159,7420.0%2.13%
-33.7%
Q1 2019$32,160,000
+24.0%
1,159,7420.0%3.21%
-3.2%
Q4 2018$25,932,000
-2.2%
1,159,7420.0%3.31%
+24.0%
Q3 2018$26,512,000
-7.8%
1,159,742
-17.7%
2.67%
-27.9%
Q2 2018$28,759,000
+32.6%
1,409,742
+21.6%
3.71%
+20.6%
Q1 2018$21,687,0001,159,7423.07%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q3 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$5,307,0251.53%
Western Standard LLC 250,060$292,5700.26%
OUP Management Co., LLC 64,000$74,8800.17%
Vivo Capital, LLC 370,068$432,9800.05%
Temasek Holdings (Private) Ltd 5,650,996$6,611,6650.04%
GEORGE KAISER FAMILY FOUNDATION 39,320$46,0040.01%
American Investment Services, Inc. 36,955$43,2380.01%
RBF Capital, LLC 58,700$68,6790.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 185,100$216,5670.01%
XTX Topco Ltd 21,188$24,7900.00%
View complete list of HOMOLOGY MEDICINES INC shareholders